About Kemwell Biopharma
Kemwell Biopharma is a company based in Bengaluru (India) founded in 1980 by Subhash Bagaria was acquired by Recipharm in April 2016.. Kemwell Biopharma has raised $5.72 million across 2 funding rounds from investors including Recipharm, Subhash Family Trust and Karan Bagaria. The company has 296 employees as of March 18, 2025. Kemwell Biopharma has completed 1 acquisition, including Cirrus Pharmaceuticals. Kemwell Biopharma offers products and services including Biologics Development, Biologics cGMP Manufacturing, Quality Control, and Formulation Development. Kemwell Biopharma operates in a competitive market with competitors including KBI Biopharma, Aldevron, Eurogentec, Ovagen and Laurus Bio, among others.
- Headquarter Bengaluru, India
- Employees 296 as on 18 Mar, 2025
- Founders Subhash Bagaria
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kemwell Biopharma Private Limited
- Date of Incorporation 07 May, 2008
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$25.37 M (USD)49.72as on Mar 31, 2024
-
Net Profit
$5.87 M (USD)690.4as on Mar 31, 2024
-
EBITDA
$13.56 M (USD)411.32as on Mar 31, 2024
-
Total Equity Funding
$5.72 M (USD)
in 2 rounds
-
Latest Funding Round
$4.26 M (USD), Unspecified
Mar 26, 2015
-
Investors
Recipharm
& 5 more
-
Employee Count
296
as on Mar 18, 2025
- Investments & Acquisitions
-
Acquired by
Recipharm
(Apr 18, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kemwell Biopharma
Kemwell Biopharma offers a comprehensive portfolio of products and services, including Biologics Development, Biologics cGMP Manufacturing, Quality Control, and Formulation Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Focuses on process and formulation for biologics therapeutics.
Produces drug substances and products under cGMP standards.
Ensures analytical testing and quality assurance for biologics.
Develops formulations for biologics drug products.
Unlock access to complete
Unlock access to complete
Funding Insights of Kemwell Biopharma
Kemwell Biopharma has successfully raised a total of $5.72M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $4.26 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Unspecified — $4.3M
-
First Round
First Round
(27 Mar 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Unspecified - Kemwell Biopharma | Valuation | Kum Kum Bagaria | |
| Mar, 2014 | Amount | Unspecified - Kemwell Biopharma | Valuation | Kum Kum Bagaria |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kemwell Biopharma
Kemwell Biopharma has secured backing from 6 investors, including institutional and angel investors. Prominent investors backing the company include Recipharm, Subhash Family Trust and Karan Bagaria. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Founded Year | Domain | Location | |
|
KB
Karan Bagaria |
Founder of KemTree, angel investor in health and wellness startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kemwell Biopharma
Kemwell Biopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cirrus Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Development services for inhaled, oral, topical, transdermal and parenteral products
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kemwell Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kemwell Biopharma Comparisons
Competitors of Kemwell Biopharma
Kemwell Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Eurogentec, Ovagen and Laurus Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Precision fermentation services for biopharma and food are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kemwell Biopharma
Frequently Asked Questions about Kemwell Biopharma
When was Kemwell Biopharma founded?
Kemwell Biopharma was founded in 1980 and raised its 1st funding round 34 years after it was founded.
Where is Kemwell Biopharma located?
Kemwell Biopharma is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Kemwell Biopharma?
Anurag Bagaria is the current CEO of Kemwell Biopharma.
Is Kemwell Biopharma a funded company?
Kemwell Biopharma is a funded company, having raised a total of $5.72M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $1.46M, raised on Mar 27, 2014.
How many employees does Kemwell Biopharma have?
As of Mar 18, 2025, the latest employee count at Kemwell Biopharma is 296.
What is the annual revenue of Kemwell Biopharma?
Annual revenue of Kemwell Biopharma is $25.37M as on Mar 31, 2024.
What does Kemwell Biopharma do?
Kemwell Biopharma was founded in 1980 and is based in Bengaluru, India. Operations focus on the biologics sector, where integrated contract development and manufacturing organization (CDMO) services are delivered. Drug substance and drug product manufacturing are handled, alongside process and analytical development. Support extends to monoclonal antibodies, fusion proteins, and other mammalian cell-culture-based protein therapeutics. Quality control and assurance are maintained in compliance with cGMP standards.
Who are the top competitors of Kemwell Biopharma?
Kemwell Biopharma's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Kemwell Biopharma offer?
Kemwell Biopharma offers Biologics Development, Biologics cGMP Manufacturing, Quality Control, and Formulation Development.
How many acquisitions has Kemwell Biopharma made?
Kemwell Biopharma has made 1 acquisition, including Cirrus Pharmaceuticals.
Who are Kemwell Biopharma's investors?
Kemwell Biopharma has 6 investors. Key investors include Recipharm, Subhash Family Trust, Karan Bagaria, Kum Kum Bagaria, and Anurag Bagaria.
What is Kemwell Biopharma's valuation?
The valuation of Kemwell Biopharma is $12.72M as of Mar 2015.